help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Willcox, N.
Right arrow Articles by Christensson, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Willcox, N.
Right arrow Articles by Christensson, B.

American Journal of Pathology, Vol 127, 447-460, Copyright © 1987 by American Society for Investigative Pathology

REGULAR ARTICLES

Myasthenic and nonmyasthenic thymoma. An expansion of a minor cortical epithelial cell subset?

N Willcox, M Schluep, MA Ritter, HJ Schuurman, J Newsom-Davis and B Christensson

The authors report an immunohistologic study of primary thymomas from 23 cases with myasthenia gravis (MG) and 7 without. Typical T6+ cortical thymocytes were usually abundant. Most epithelial cells initially appeared to be of cortical type, too, though many bore subcapsular markers in most samples. However, two-color immunofluorescence revealed unexpected heterogeneity, numerous epithelial cells simultaneously expressing some or all of the markers of both these subsets (even in two pleural metastases). It is inferred that there is a common tumor stem cell whose normal counterpart may be related to the rare patches of similar phenotype in the cortex in control samples. The authors could detect no major differences in 5 of 7 samples from nonmyasthenics; thus, most thymoma cases may risk the development of MG. Finally, thymomas from 6 of 7 further MG cases pretreated with corticosteroids showed very few cortical thymocytes, and the (phenotypically similar) epithelium was more obvious.


This article has been cited by other articles:


Home page
 J. Thorac. Cardiovasc. Surg.Home page
M. Okumura, M. Ohta, Y. Takeuchi, H. Shiono, M. Inoue, K. Fukuhara, Y. Kadota, S. Miyoshi, Y. Fujii, and H. Matsuda
The immunologic role of thymectomy in the treatment of myasthenia gravis: implication of thymus-associated B-lymphocyte subset in reduction of the anti-acetylcholine receptor antibody titer
J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1922 - 1928.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
H. Shiono, Y. L. Wong, I. Matthews, J.-L. Liu, W. Zhang, G. Sims, A. Meager, D. Beeson, A. Vincent, and N. Willcox
Spontaneous production of anti-IFN-{alpha} and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor
Int. Immunol., August 1, 2003; 15(8): 903 - 913.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Inoue, P. Starostik, A. Zettl, P. Strobel, S. Schwarz, F. Scaravilli, K. Henry, N. Willcox, H.-K. Muller-Hermelink, and A. Marx
Correlating Genetic Aberrations with World Health Organization-defined Histology and Stage across the Spectrum of Thymomas
Cancer Res., July 1, 2003; 63(13): 3708 - 3715.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Inoue, A. Marx, A. Zettl, P. Strobel, H.-K. Muller-Hermelink, and P. Starostik
Chromosome 6 Suffers Frequent and Multiple Aberrations in Thymoma
Am. J. Pathol., October 1, 2002; 161(4): 1507 - 1513.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by the American Society for Investigative Pathology.